CN117898349A - 一种解酒护肝保健茶 - Google Patents
一种解酒护肝保健茶 Download PDFInfo
- Publication number
- CN117898349A CN117898349A CN202311697883.1A CN202311697883A CN117898349A CN 117898349 A CN117898349 A CN 117898349A CN 202311697883 A CN202311697883 A CN 202311697883A CN 117898349 A CN117898349 A CN 117898349A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver
- alcohol
- tea
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 58
- 210000004185 liver Anatomy 0.000 title claims abstract description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 241001122767 Theaceae Species 0.000 title claims description 60
- 239000000843 powder Substances 0.000 claims abstract description 39
- 241001116389 Aloe Species 0.000 claims abstract description 30
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 30
- 241000208688 Eucommia Species 0.000 claims abstract description 22
- 241000723353 Chrysanthemum Species 0.000 claims abstract description 20
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 20
- 241000244938 Penthorum chinense Species 0.000 claims abstract description 20
- 230000002075 anti-alcohol Effects 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 238000007873 sieving Methods 0.000 claims description 12
- 241001018563 Nekemias grossedentata Species 0.000 claims description 9
- 241000208689 Eucommia ulmoides Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 239000004677 Nylon Substances 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229920001778 nylon Polymers 0.000 claims description 7
- 238000000643 oven drying Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims 1
- 230000035622 drinking Effects 0.000 abstract description 27
- 239000003814 drug Substances 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000006378 damage Effects 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 abstract description 5
- 208000014674 injury Diseases 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 5
- 230000002936 tranquilizing effect Effects 0.000 abstract description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract description 4
- 108010082126 Alanine transaminase Proteins 0.000 abstract description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 abstract description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract description 3
- 108010012715 Superoxide dismutase Proteins 0.000 abstract description 3
- 230000001575 pathological effect Effects 0.000 abstract description 3
- 229930015704 phenylpropanoid Natural products 0.000 abstract description 3
- 125000001474 phenylpropanoid group Chemical group 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 2
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract description 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- 239000001301 oxygen Substances 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 235000013616 tea Nutrition 0.000 description 48
- 206010067125 Liver injury Diseases 0.000 description 7
- 231100000753 hepatic injury Toxicity 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 230000001476 alcoholic effect Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种解酒护肝保健茶,属于解酒中药或保健茶技术领域,其由芦荟精粉、杜仲雄花、陈皮、菊花、藤茶、赶黄草组成;其中各原料均为药食同源的材料,方中杜仲雄花作君药,用于安神镇静,补中益气;芦荟精粉和陈皮为臣药,用于泻热导滞,理气健脾;菊花和赶黄草为佐药,用于疏风清热,利水除湿;藤茶为使药,调和助运诸药;几种原料中所含有的活性成分相辅相成,协同增效,可协同提高环烯醚萜类和苯丙素类的活性,进而升高体内超氧化物歧化酶活性,清除酒后细胞产生的大量氧自由基,减轻其对细胞造成的损害,同时保护细胞膜稳定性,显著降低血清谷丙转氨酶、谷草转氨酶,修复肝脏的病理损伤,在提高解酒效果的同时保护肝脏。
Description
技术领域
本发明属于解酒中药或保健茶技术领域,特别是一种解酒护肝保健茶。
背景技术
我国饮酒历史悠久,适量饮酒有益身体健康,但过量饮酒会对人体健康产生严重的影响,酒精进入人体后,是通过肝脏来代谢的,在多种酶和维生素的参与下,先把乙醇转化为乙醛,最后分解为二氧化碳和水排出体外,这些过程都是在肝脏中进行的,过度饮酒将破坏神经系统正常功能,导致慢性胃炎、肝硬化等一系列疾病的产生,因饮酒而造成的肝病问题也越来越多。
目前市场上的解酒产品大致包括化学药品、中药制剂和保健品等,主要是以保肝护肝为主,对解酒效果并不明显,且其中化学成分有很强的副作用;因此,提供一种纯天然无副作用,具有解酒兼顾保肝护肝作用的茶饮是本发明需要解决的技术问题。
发明内容
针对现有技术中的上述缺陷和问题,本发明实施例的目的是提供一种安全可靠,
对解酒效果明显,兼顾保肝护肝,无副作用,经济实惠的茶饮。
为解决上述技术问题,本发明所采用的技术方案是一种解酒护肝保健茶,其由芦荟精粉、杜仲雄花、陈皮、菊花、藤茶、赶黄草组成。
一般的,所述解酒护肝保健茶由如下重量份的原料制成:芦荟精粉1~20份、杜仲雄花1~20份、陈皮5~15份、菊花5~10份、藤茶1~5份、赶黄草1~5份。
进一步的,所述解酒护肝保健茶由如下重量份的原料制成:芦荟精粉5~15份、杜仲雄花5~15份、陈皮10~12份、菊花6~8份、藤茶2~4份、赶黄草2~4份。
进一步的,所述解酒护肝保健茶由如下重量份的原料制成:芦荟精粉11份、杜仲雄花12份、陈皮11份、菊花7份、藤茶3份、赶黄草3份。
上述中,各种原料药均含有对解酒有益的活性成分,经过合理配伍后产生协同增
效的作用,因而能够迅速有效的解酒。其中:
所述杜仲雄花就是杜仲雄树开的花,自古就有很高的药用价值,其天然活性成分具有安神、镇静及镇痛作用;其母体杜仲,味甘,温,无毒,主治腰脊痛,补中,益精气,坚筋骨,除阴下痒湿,小便余沥,久服轻身耐老;现代医学研究表明,杜仲雄花中含有的环烯醚萜类和苯丙素类等活性成分,能够有效分解酒精,降低酒精对人体的危害,并且对于肝脏也有很好的保护作用。
所述芦荟精粉由芦荟凝胶冻干制成,其母体芦荟具有泻热导滞,消疳杀虫,清热凉肝的作用,为泻肝火、消疳积之功效;由芦荟凝胶制成的芦荟精粉能降低酒精分解后产生的有害物质乙醛在血液中的浓度,对预防酒后头痛和恶心、脸红等症状有非常好的效果,此外,芦荟精粉中的苦味成分芦荟素有健胃作用,可治疗宿醉引起的反胃
和恶心等;
所述陈皮具有理气健脾,燥湿化痰的功效,主治脘腹胀满,食少吐泻,咳嗽痰多;
现代医学研究表明,陈皮中含有柠檬苦素,能够加快人体肠道蠕动,不仅能帮助促进消化,还能加快酒精在人体内的清除速度;另陈皮中还含有挥发油、橙皮甙等成分,这些成分可以促进人体消化液的分泌,帮助排尿、排汗。
所述的菊花具有疏风清热、明目解毒之功效,主要治疗头痛、眩晕、目赤、心胸烦热、疔疮、肿毒等症,现代药理研究表明,菊花具有治疗冠心病、降低血压、预防高血脂、抗菌、抗病毒、抗炎、抗衰老等多种药理活性;其中含有的绿原酸、木犀草素对酒精性肝损伤细胞有保护作用,其水提物可以抑制肝脏的氧化应激,进而改善酒精诱导的肝损伤。
所述赶黄草具有利水除湿,祛瘀止痛之功效,用于黄疸,水肿,跌打损伤,肿痛;
现代医学研究表明,赶黄草中含有的槲皮素对酒精性肝损伤有防护作用,并且还能通过调节溶酶体酶的活性发挥拮抗效应,同时槲皮素对酒精性脂肪肝病也有一定的治疗作用。
藤茶为显齿蛇葡萄叶干制品,对酒精性肝损伤有预防和治疗作用,其包含的黄酮成分能减缓化学性肝损伤引起的血清谷丙转氨酶、谷草转氨酶活性的升高,降低肝组织匀浆中丙二醛的含量,增强超氧化物歧化酶的活性,减轻酒精对肝脏细胞的病理损伤;
本发明所述的解酒护肝保健茶中,各原料均为药食同源的材料,方中杜仲雄花作为君药,用于安神镇静,补中益气,起到主要作用;芦荟精粉和陈皮作为臣药,用于泻热导滞,理气健脾,起辅助作用;菊花和赶黄草作为佐药,用于疏风清热,利水除湿,起辅助作用,藤茶作为使药,调和助运诸药,起辅助作用;几种原料中所含有的活性成分相辅相成,协同增效,可协同提高环烯醚萜类和苯丙素类的活性,进而升高体内超氧化物歧化酶活性,清除酒精中毒后阻止、细胞产生的大量氧自由基,减轻其对细胞造成的损害,同时保护细胞膜稳定性,促进酒精的分解和代谢,同时,能显著降低血清谷丙转氨酶、谷草转氨酶,修复肝脏的病理损伤,在提高解酒效果的同时,保护肝脏。
所述解酒护肝保健茶的制备方法为:将芦荟精粉过筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末;充分混匀后将粉末装入环保尼龙滤布包袋中,每袋10g。
上述中,所述芦荟精粉过80目筛,杜仲雄花、陈皮、菊花、藤茶、赶黄草粉末过30~70目筛。
其有益效果是采用了药食同源的材料进行合理组方而成,通过各组分之间的协同作用,可以显著增加解酒效果,使本保健茶具有有效的解酒护肝的作用,冲泡饮用后能加速肝脏对酒精的代谢,减少毒素在体内的堆积,对肝脏有明显保护作用,还具有安神镇静,补中益气,理气健脾、利水除湿的功能。
具体实施方式
下面结合实施例对本发明技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种解酒护肝保健茶,所述原料的重量配比为:芦荟精粉1份、杜仲雄花1份、陈皮5份、菊花5份、藤茶1份、赶黄草1份。
将芦荟精粉过80目筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末并过30目筛,将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g;饮用时每次冲泡1袋,饮酒后开水泡饮代茶。
实施例2
一种解酒护肝保健茶,所述原料的重量配比为:芦荟精粉5份、杜仲雄花5份、陈皮10份、菊花6份、藤茶2份、赶黄草2份。
将芦荟精粉过80目筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末并过40目筛,将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g;饮用时每次冲泡1袋,饮酒后开水泡饮代茶。
实施例3
一种解酒护肝保健茶,所述原料的重量配比为:芦荟精粉15份、杜仲雄花15份、陈皮12份、菊花8份、藤茶4份、赶黄草4份。
将芦荟精粉过80目筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末并过50目筛,将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g;饮用时每次冲泡1袋,饮酒后开水泡饮代茶。
实施例4
一种解酒护肝保健茶,所述原料的重量配比为:芦荟精粉11份、杜仲雄花12份、陈皮11份、菊花7份、藤茶3份、赶黄草3份。
将芦荟精粉过80目筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末并过60目筛,将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g;饮用时每次冲泡1袋,饮酒后开水泡饮代茶。
实施例5
一种解酒护肝保健茶,所述原料的重量配比为:芦荟精粉20份、杜仲雄花20份、陈皮15份、菊花10份、藤茶5份、赶黄草5份。
将芦荟精粉过80目筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末并过70目筛,将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g;饮用时每次冲泡1袋,饮酒后开水泡饮代茶。
试验例1:解酒护肝保健茶的护肝效果试验。
取实验小鼠随机分为空白对照组、饮酒对照组、本发明实施例1产品组、本发明实施例2产品组、本发明实施例3产品组、本发明实施例4产品组、本发明实施例5
产品组,每组20只。前30天每组给予正常饮食和饮蒸馏水,其后30天,即从第31
天起到第60天,每组除继续给予正常饮食和饮蒸馏水外,然后除空白对照组外,饮酒对照组、本发明实施例1产品组、本发明实施例2产品组、本发明实施例3产品组、本发明实施例4产品组、本发明实施例5产品组,每组中午12时灌胃52度白酒,灌胃剂量为8ml/kg,相当于体重50公斤的人每天每次饮高度白酒8两,然后饮酒对照组任其饮蒸馏水,本发明实施例1产品组、本发明实施例2产品组、本发明实施例3产品组、本发明实施例4产品组、本发明实施例5产品组各自任其应用相应组别的解酒护肝保健茶冲泡的茶水;60天后,取各组小鼠血液样本和肝脏组织进行指标检测。
实验小鼠的血清ALT和AST检测结果,如表1。
组别 | ALT(U/L) | AST(U/L) | 肝脏指数(%) |
空白对照组 | 28.33±4.55 | 29.67±10.66 | 3.77±0.53 |
实施例1产品组 | 36.22±4.77 | 40.11±10.53 | 4.11±0.53 |
实施例2产品组 | 33.45±4.25 | 37.32±11.56 | 4.03±0.51 |
实施例3产品组 | 31.35±3.57 | 35.61±11.33 | 4.01±0.33 |
实施例4产品组 | 33.05±3.17 | 37.55±9.38 | 4.03±0.46 |
实施例5产品组 | 35.75±4.35 | 39.57±10.87 | 4.10±0.57 |
饮酒对照组 | 53.28±5.42 | 63.65±15.54 | 5.22±0.73 |
表中ALT和AST是肝功能的重要指标,其中谷草转氨酶AST正常值是8-50U/L。谷丙转氨酶ALT正常值是5-40U/L。肝脏指数(%)=肝脏重量(g)/体重(g)*100%,为酒精性肝损伤动物模型的主要表观指标,肝指数高表示肝脏重量增加,存在肝细胞水肿。
由表1可知:
空白对照组的血清指标与饮酒对照组及各个实施例产品组相比,ALT和AST的含量及肝脏指数均明显低于饮酒对照组及各个实施例组,说明在长时间灌胃高度酒后给实验小鼠的肝脏已经造成了损伤。
本发明各个实施例产品组与饮酒对照组相比,ALT和AST的含量及肝脏指数均显著低于饮酒对照组,可见,饮用本发明解酒护肝保健茶,能够对酒后肝脏损伤具有良好的保护作用,能够大大减少酒精肝脏的损伤;其中,实施例3产品组的效果最好。
本发明各个实施例产品组与空白对照组相比,ALT和AST的含量及肝脏指数均高于空白对照组,可见,即使饮用解酒护肝保健茶,长期饮酒也会对肝脏造成损伤。
试验例2:解酒护肝保健茶的解酒效果试验。
以下通过试验例进一步阐述本茶饮的效果:
1、试验对象:
随机选取饮酒过量后表现头晕、头痛、恶心呕吐、意识模糊、走路不稳等症状的醉酒者100例,年龄范围30~55岁,其中男81名,女19名。按照找到醉酒者出现的先后秩序依次饮用本发明实施例1产品、本发明实施例2产品、本发明实施例3产品、本发明实施例4产品、本发明实施例5产品;每组20例。
2、疗效标准:
显效:观察解酒护肝保健茶对酒醉患者的疗效,能显著改善酒醉引起的头晕、头痛、恶心呕吐、意识模糊、走路不稳等症状。
有效:观察解酒护肝保健茶对酒醉患者的疗效,能有效改善酒醉引起的头晕、头痛、恶心呕吐、意识模糊、走路不稳等症状。
无效:观察解酒护肝保健茶对酒醉患者的疗效,未能改善酒醉引起的头晕、头痛、恶心呕吐、意识模糊、走路不稳等症状。
3、服用方法:
醉酒后开水冲泡解酒护肝保健茶,饮用不限量,一次一袋或两袋;1-3小时后观察饮用者的表现。
4、饮用效果,如表2:
可见,饮用本解酒护肝保健茶对醉酒者效果显著,其中显效:47例;有效:34例;
无效:19例,总有效率:81.0%。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (6)
1.一种解酒护肝保健茶,其特征在于其由芦荟精粉、杜仲雄花、陈皮、菊花、藤茶、赶黄草组成。
2.根据权利要求1所述的解酒护肝保健茶,其特征在于由如下重量份的原料制成:芦荟精粉1~20份、杜仲雄花1~20份、陈皮5~15份、菊花5~10份、藤茶1~5份、赶黄草1~5份。
3.根据权利要求1所述的解酒护肝保健茶,其特征在于所述解酒护肝保健茶由如下重量份的原料制成:芦荟精粉5~15份、杜仲雄花5~15份、陈皮10~12份、菊花6~8份、藤茶2~4份、赶黄草2~4份。
4.根据权利要求1所述的解酒护肝保健茶,其特征在于所述解酒护肝保健茶由如下重量份的原料制成:芦荟精粉11份、杜仲雄花12份、陈皮11份、菊花7份、藤茶3份、赶黄草3份。
5.根据权利要求1所述的解酒护肝保健茶,其特征在于所述解酒护肝保健茶的制备方法为:将芦荟精粉过筛,将杜仲雄花、陈皮、菊花、藤茶、赶黄草分别烘干后粉碎成粉末;将各个粉末充分混匀后装入环保尼龙滤布包袋中,每袋10g。
6.根据权利要求1所述的解酒护肝保健茶,其特征在于所述芦荟精粉过80目筛,杜仲雄花、陈皮、菊花、藤茶、赶黄草粉末过30~70目筛。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311697883.1A CN117898349A (zh) | 2023-12-12 | 2023-12-12 | 一种解酒护肝保健茶 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311697883.1A CN117898349A (zh) | 2023-12-12 | 2023-12-12 | 一种解酒护肝保健茶 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117898349A true CN117898349A (zh) | 2024-04-19 |
Family
ID=90691394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311697883.1A Pending CN117898349A (zh) | 2023-12-12 | 2023-12-12 | 一种解酒护肝保健茶 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117898349A (zh) |
-
2023
- 2023-12-12 CN CN202311697883.1A patent/CN117898349A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107518133A (zh) | 一种解酒护肝花茶及其制备方法 | |
CN106689933A (zh) | 一种富含天然成分提取物的解酒护肝饮料及其制备方法 | |
CN102920806B (zh) | 安神降压中药茶 | |
KR101826737B1 (ko) | 생약재 추출물을 유효성분으로 하는 근육틱 및 우울증 개선용 조성물 및 그의 제조방법 | |
CN106617049A (zh) | 一种含辣木叶提取物的蜂胶类保健品及其制备方法 | |
CN109480011A (zh) | 一种具有养胃护肝功能的解酒茶及其制备方法 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
CN103006922A (zh) | 一种具有解酒护肝功能的组合物 | |
CN104694315B (zh) | 一种防衰老葡萄酒及制备方法 | |
CN110973625A (zh) | 基于火麻仁的护肝醒酒组合物及其制备方法和应用 | |
CN114631632B (zh) | 一种护肝解酒的刺梨组合物及其制剂与应用 | |
CN114569686B (zh) | 一种解酒组合物、具有解酒功效的片剂及其制备方法 | |
CN107441429B (zh) | 一种解酒组合物及其制备方法 | |
KR101365794B1 (ko) | 숙취해소 및 간 보호기능 개선 조성물 | |
CN114767826A (zh) | 一种醒酒护肝组合物、具有醒酒护肝功效的饮料及其制备方法 | |
CN117898349A (zh) | 一种解酒护肝保健茶 | |
CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
CN111905087A (zh) | 一种解酒保肝养生保健品组方 | |
CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
CN110558409A (zh) | 一种具有醒酒作用的中药养生茶及其制备方法 | |
CN117694533B (zh) | 一种荔枝膜植物功能饮料及其制备方法 | |
KR102341886B1 (ko) | 벌나무 추출물 및 오리나무 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
RU2792449C2 (ru) | Состав фиточая, содержащего биологически активные добавки | |
CN112314946A (zh) | 一种玫菊口服液及其制备方法和抗疲劳用途 | |
CN117180351A (zh) | 一种解酒护肝组合物、解酒护肝制剂及制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |